Russian market at a crossroads: still emerging and attractive, despite going through hard times
|
|
- Adela Lewis
- 6 years ago
- Views:
Transcription
1 Russian market at a crossroads: still emerging and attractive, despite going through hard times Nickolai Demidov General manager IMS Health Russia&CIS
2 Executive summary Market overview Russian pharmaceuticals market entered into a period of major external and internal challenges from the end of 214 that are causing changes in out of pocket and state sectors. IMS Health outlined a few major factors and drivers that might have relevant impact in the aftermath of this crisis. General trends Drop of disposable income and purchasing power for both private and state sectors Enforcement of the support for local manufacturers Price regulation for EDL drugs Threat of deficit as a trigger for different regulative novellas Out of pocket sector trends& key factors Lessons learnt from the previous crisis on OOP market Regulation of price registration and adjustment in EDL Out of pocket turned to practically only price-driven OOP market growth Managing the price within the supply chain Government sector challenges and trends Budget cuts for healthcare at Federal Regional levels Variations within different programs healthcare reforms and deficit of CMIF Localization trends for state purchases
3 Russia entered a period of economic turmoil Russian GDP dynamics, trillion rubles in constant prices -3.4%* E Real disposable income dynamics, % change to the previous year -7 pp. 15.9% 1.5% 14.6% 13.2% 99.2% 92.2% E Unemployment rate dynamics, % of economically active population +.6 pp 7.3% 6.5% 5.7% 5.7% 5.4% 6.% Macroeconomic outlook is worsening due to: Sanctions Further drop in oil prices According to government estimates there will be sharp drop in real disposable income of population in 215 that will lead to significant drop in purchasing power Unemployment rate is expected to hit its peak since 211 and reach 6% of economically active population E * as of August the 3 rd, 215 IMF forecast update Source: IMF, Base case forecast as of May 28 th, 215, prepared by Ministry for economic development, IMS analysis Stada Capital Markets Day 215 Saint Petersburg
4 Healthcare and pharmaceuticals spending in Russia Dynamics of public expenditures on healthcare, % of GDP 3.7% 3.6% 3.8% 4.3% 4.1% Additionally planned increase Percentage of GDP Pharmaceuticals market in Russia, billion rubles % 33% 35% 35% 65% 65% 65% 67% +13% % 66% 5.5% 1.4% 4.1% 215E % 64% Healthcare spending level is expected to remain unchanged (4.1% of GDP) Potential increase (1,4% of GDP) planned by the government is under question Spending on pharmaceuticals in Russia is expected to grow by 13% primarily due to price inflation in the Economy E Budget procurement Retail Source: Ministry of Finance, IMS Market Prognosis , IMS analysis Stada Capital Markets Day 215 Saint Petersburg
5 Budget spending, trillion rub CPI, index Economic crisis USD/ RUB exchange rate Oil price per barrel, USD General trends Russia entered a period of economic turmoil (3 / 3) Ruble devaluation and oil price Comments Average USD/RUB exchange rate Average spot price on crude oil, USD Russian government has 2 options driven by the crisis caused by external events: 7 14, 15, 14,1 97, 96,3 6 79, 5 61,8 38,6 4 3,3 29,4 31,1 31,8 3 24,8 31, CPI and Russia budget expenditures dynamics 61,5 59,3 215E To allow ruble easing and maintain same budget spending 2. To maintain exchange rates, inflation and allow budget cuts Russian government is more inclined to drop exchange rate and maintain budget spending nominated in rubles, as observed historically Devaluation in focus CPI, index (IMF, IMS estimates) 2, 16, 17,6 14,2 Russia budget expenditures, trillion rub 29,4 27, ,3 23, week Ruble makes the localization of production in Russia more attractive then ever; the potential decrease of local demand may be compensated by increased export E Source: IMF, Ministry for economic development, IMS estimations, IMS experts
6 Key government initiatives on pharmaceutical market regulation in are in line with general import substitution policy N Government initiative Status Impact on pharma 1 Essential drugs list review in 215 Several new products included 2 Support of local manufacturers for loans disbursement Minor, for several domestic companies 3 Import substitution plan approval General guidance and targets 4 5 Parallel imports of certain product categories legalization To come into force from 1 st January 216 Localization: from packaging to full cycle To come into force from 1 st January One-time price adjustment for EDL New order of price registration for EDL, To come into force from 1 st January 216 Preferences for domestic in government purchases ( the third is odd rule) To come into force from 1 st January 216 System of monitoring of the product journey from manufacture to patient (labeling) Draft law on mode of production of patented products at Russian plants???? Headache for manufacturers; Potential new market for new whls Reflashing of product delivery to the market models Joker in the deck of the regulator that is wasn t used so far Controversial: tight procedure though indexation of price for all Procedure looks rather complex to be effective; might change the balance in generic including bio Increase of cost vs. increase of market transparency Might change the paradigm of innovative business in Russia Sources: Ministry of Health, Government press releases, government acts, experts interviews
7 SALES BY VALUE, RUB BLN SALES BY VOLUME, BLN PACKS Pharma market growth in H1 215 Market grew by 11% in value, but it is still shrinking in volume Value Volume % 388 2,4-8% 2, % 261 Retail Hospital Federal Reimb 2,1-8% 1,9 57 6% 61-6% 54 21% 66,3 1%,3 H1 14 H1 15 H1 14 H1 15 Indicator RUB $ EURO Packs Value H1 215, Bln Growth H1 15/H1 14,% Source: IMS Health. TRD prices 11% -32% -17% -8% Stada Capital Markets Day 215 Saint Petersburg
8 SALES BY VALUE, RUB BLN Top 1 producers by sales value in H1 215 Outpacing growth is concentrated outside top 1 group % 17,3 1,7 2,2 % 12,8 2,5 8% 11,9,2 4% 7,6,4 3,8 23% 9% 2% 9, 9,3 9,1 1,4,6 TOP-1 market concentration in H1 215: 36% H1 214: 32% 3-33% 1,2 2,3 6,2-26% 4,6 2, 2,8 12% 7,6, GROWTH,YOY,% Novartis SA Bayer Teva Takeda Servier Stada Roche J&J Gedeon Retail Hospital DLO Source: IMS Health. TRD prices Stada Capital Markets Day 215 Saint Petersburg
9 SALES BY VALUE, RUB BLN SALES BY VOLUME, BLN PACKS Retail market growth in H1 215 Split by prescription status Value Volume % 261 2,1-8% 1, % 129 Rx,6-7%,6 OTC % 132 1,5-9% 1,3 H1 14 H1 15 H1 14 H1 15 Source: IMS Health. TRD prices. Retail sales only Stada Capital Markets Day 215 Saint Petersburg
10 SALES BY VALUE, RUB BLN SALES BY VOLUME, BLN PACKS Retail Rx market in H1 215 Split by EDL status Value Volume % 129,6-7%, % 66 Non EDL EDL,2-9%,2 7% %,4,4 H1 14 H1 15 Source: IMS Health. TRD prices. Retail Rx sales only H1 14 H Stada Capital Markets Day 215 Saint Petersburg
11 Growth structure on retail market in H1 215 X Analysis of the structure of growth in EDL and Non-EDL segments shows similar oiewre trends Prices grew significantly in both sub-segments on wrrrrrrrr EDL 3% retail market. The main difference is in the scale of rrrrrrrrrr inflation process 1% rrrrrrrrrr 1% 8% rrrrrrrrrr Prices for EDL products increased by 6% 1%YoY in H1 15 rrrrrrrrrr rrrrrrrrrr -,1 rrrrrrrrrr rrrrrrrrrr Drop-out products* rrrrrrrrrr rrrrrrrrrr rrwww wwww wwww wwwwt r, Inflation 25% More expensive 2% Volume Non EDL 14% New products 12% Drop-out Inflation More Volume New Total products* expensive products Growth Source: IMS Health. Data at TRD prices, drop-out products are excluded due to low figures 2% Total Growth Price increase for Non-EDL products accounted for 25% IMS monthly analysis shows no price increase since February. It means that inflation probably has already achieved its max effect EDL in Russia >6 preparations >6% of the market in value basis for government purchases and for future reimbursement ex-man prices is to be registered, whls &retail markups are limited Stada Capital Markets Day 215 Saint Petersburg
12 Key products categories in OOP market in 1H 215 Branded generics dominate at the OOP and keep growing faster then market average, though consumption strongly declined Product categories, MS%, by value 6,1% 33,2% 5,2% 55,5% generics and never protected not covered original protected Product categories growth, by values/volumes 11,5% 1,2% -8,4% generics and never protected -6,6% -3,7% -15,1% 15,5% -3,2% not covered original protected Gr value, % (RUB) Gr volume, % Generics, MS%, by value Generics growth, by values/volumes 5,9% 3 26% 23% 13,2% BRANDED 2 12% INN UNBRANDED 1 Gr value, % (RUB) 8,9% COMPANY BRANDED -1 BRANDED -7,2% INN -4,4 UNBRANDED COMPANY BRANDED -2,53% Gr volume, % Source: IMS Health. Retail sales; RX/OTC; TRD prices Stada Capital Markets Day 215 Saint Petersburg
13 SALES BY VALUE, RUB BLN SALES BY VOLUME, MLN PACKS DLO market in H1 215 Sales growth is being largely driven by ONLS segment in H1 215 Value Volume +21% +1% ,2 2,5 17% 52,9 2, % 7N ONLS 45,6 1% 5, 22 4% 31 H1 14 Source: IMS Health. Contract prices H Stada Capital Markets Day 215 Saint Petersburg H1 14 H1 15 INN generics/local biological/innovations, limited room for branded generics Tender based market regulator push for lowest price Localization leverage the access, to be more important in future
14 Pharmacy chains & distributors OOP sector trends Importance of pharmacy chains is growing due to business consolidation and capture of significant market share Context pharmacy chains in Russia accumulated around 61% of total retail sales(in value term) in 215/16 and this trend is expected to continue there is no limitation on chain ownership in Russia but competition legislation limits maximum market share belonging to chain in region chains are privately owned; the biggest are fast developing and expanding with different formats, location and positioning TOP-1 chains occupies 2% of local market; there 3 chains with more then 1 outlets and 6 with 5 pharmacies the biggest chain 36,6 has 3,3% of national market in value terms with 783 while the biggest chain in terms of outlets # - >16 and only 2,1% (due to regional coverage specifics) marketing unions and other type of virtual chains already become a strong tool for negotiation with suppliers and is to get stronger with new types of collaboration Source: IMS Health; SCI; 2 interviews with chains
15 Wholesaler segment joins the race of consolidating through M&A Context Top-1 Wholesalers in Russia accumulated around 82% of total direct drug sales (in value term) in 1H 215 Wholesalers in Russia are usually providing full range of service (logistics/warehousing/documentary) based on setting margin on ex-manufacturer price Pharmacy chains & distributors OOP sector trends The wholesalers tend to have 2 types of specialty full range wholesaling mainly focused on dealing with pharmacy retail (rather consolidated and stable) and tender players Most of TOP full range wholesalers has expanded into neighboring areas, mainly pharmacy retail, by creating their own chains (also virtual). Some also invested in production aimed for localization services for international pharma Like in retail chains Consolidation process through M&A is also continuing in Distributor segment (Ave Group bought Russian subsidiary of Oriola; R-Pharm is in process of acquiring of SIA Int.) Currently wholesalers in Russia are trying to leverage some short term benefits the exchange rate fluctuations provided along with optimization of the business. In long term they might become under threat of bankruptcy as the models they apply requires constant access to cheap long term funding of trade operation which might be eroded in Russia if the macroeconomic situation will be further worsening Source: IMS Health; SCI; 2 interviews with chains
16 Scale of crisis sustainability for different types of pharma companies in Combination of branded /INN/company branded generics (EDL <4%) New bio generics for gov purchases Rx EDL free portfolio with underestimated price INN generics Low risk Diversified portfolio of non EDL/OTC/innovations (MNCs) High margin innovative Products with low elasticity of demand Local production of branded generics Sustainable High portion (>7%) of EDL products Low margin innovative in gov. purchases Newly launched innovative products Expensive OTCs with low differentiation Products with high elasticity of demand High risk Stada Capital Markets Day 215 Saint Petersburg
17 Drivers Political situation added new uncertainties in a long prospect Though the market is to have a deep decline in 215, the most likely scenario for is the restore of the average yearly growth close to 1% Total Pharmaceutical market Sales LC$B (ex-mnf), ,2 8,8 11% 1,2 11,2 12,1 Source: IMS Health, Market Prognosis March ,7 15,2 Devaluation of Ruble affected the market drastically in 215. Further restore of the market in one of the scenarios might bring back to faster growth -45%- -5% E 215E 216E 217E 218E 219E 8,9 9% 16,2 17,6 19,2 21, Wild cards Duration and scale of sanctions Situation on commodity markets Drivers Price increases along with sustainable purchasing power of population and state budget Market restore in (?) Introduction of Drug insurance in a long term range Constraints Weak macroeconomic outlook New preferences for local production Constrains for price growth in EDL Stada Capital Markets Day 215 Saint Petersburg 215 IMS Health Incorporated or its affiliates. All rights reserved
Russian market evolvement in crisis mode, first insights of 2016 and further outlook. Demidov Nickolai General manager IMS Health, Russia&CIS
Russian market evolvement in crisis mode, first insights of 2016 and further outlook Demidov Nickolai General manager IMS Health, Russia&CIS 1 Whole market Russian pharmaceutical market grew by 10% terms
More informationPharmaceutical market structure
Pharmaceutical market structure Russian pharmaceutical market volume in 2015 ~ 1 045 billion, RUR* / 17,3 billion $* Consumer money State budget RETAIL 66,6 % 13,5 % Reimbursement 16% 2015 13% 4% Retail
More informationPharma market outlook in the background of stabilization observed in 2016
Pharma market outlook in the background of stabilization observed in 8 th of February 2017 Demidov Nickolai, GM QuintilesIMS, Russia&CIS Copyright 2017 QuintilesIMS. All rights reserved. Contents Key macro
More informationFacts from IQVIA M Copyright 2017 IQVIA. All rights reserved.
Facts from IQVIA M01 2018 Copyright 2017 IQVIA. All rights reserved. Russia pharma market growth in January 2018 Market decreases by -19% in value and -8,3% in volume VALUE, BLN RUB VOLUME, BLN PACKS 90-19%
More informationPrice regulation models in Turkey and the Russian Federation. Panos Kanavos London School of Economics NPPA Seminar, New Delhi, April 2008
Price regulation models in Turkey and the Russian Federation Panos Kanavos London School of Economics NPPA Seminar, New Delhi, April 2008 The context: Why Turkey and Russia? Attribute Implementing Health
More informationDrug Reimbursement - Croatia. Roganovic Jelena
Drug Reimbursement - Croatia Roganovic Jelena Population: 4,292,095 (July 2017) Area: 56,594 km 2 Density: 75.8/km 2 21 counties http://www.lokalniizbori.com/wp-content/uploads/2013/04/hrvatska-%c5%beupanije.jpg;
More informationDistribution of medicines in the Czech Republic
12/4/217 Distribution of medicines in the Czech Republic Hynek Valerián Copyright 217 IQVIA. All rights reserved. Czech pharmaceutical market 1 1 12/4/217 Terminology note Rx-bound medicines/otc medicines
More informationThe Russian pharmaceutical market. Marina Veldanova Managing Director Polpharma Russia
The Russian pharmaceutical market Marina Veldanova Managing Director Polpharma Russia EGA ANNUAL CONFERENCE - ISTANBUL JUNE 2007 Agenda: 1. Russian pharmaceutical market vs. another ones. 2. RPhM s structure
More informationMACROECONOMIC FORECAST
MACROECONOMIC FORECAST Autumn 2017 Ministry of Finance of the Republic of Bulgaria The Autumn macroeconomic forecast of the Ministry of Finance takes into account better performance of the Bulgarian economy
More informationFOR IMMEDIATE RELEASE 19 March 2010 A&D PHARMA HOLDINGS N.V. UNAUDITED FINANCIAL STATEMENTS FOR THE 12 MONTHS ENDED 31 DECEMBER 2009
FOR IMMEDIATE RELEASE 19 March 2010 A&D PHARMA HOLDINGS N.V. UNAUDITED FINANCIAL STATEMENTS FOR THE 12 MONTHS ENDED 31 DECEMBER 2009 18% year-on-year RON denominated consolidated sales growth 3% year-on-year
More informationTABLE OF CONTENTS 1. INTRODUCTION 2. OIL & GAS 3. REAL ESTATE & CONSTRUCTION 4. WHOLESALE & RETAIL 5. OUTLOOK 1. INTRODUCTION
Russia Industry Research Corporates 5 December Authors: Vladimir Gorchakov Gustavo Angel Hector Alvarez Marko Denic Research Assistant For Further Information Contact: Rating-Agentur Expert RA GmbH Walter-Kolb-Strasse
More informationThe Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE**
The Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE** Pharmaceutical, commercial and strategic developments in the Brazil, Russia, India & China Over-the- Counter
More informationO KEY GROUP ANNOUNCES AUDITED FINANCIAL RESULTS FOR FY2016
Press Release 30 March 2017 O KEY GROUP ANNOUNCES AUDITED FINANCIAL RESULTS FOR FY2016 O KEY Group S.A. (LSE: OKEY, the Group ), one of the leading Russian food retailers, announces its full year 2016
More informationThe Dawn of a New Economic Era? Russia Economic Report April 2015 Edition No. 33
The Dawn of a New Economic Era? Russia Economic Report April 2015 Edition No. 33 Main messages 1 Russia s economy experienced two shocks in 2014, but avoided a recession A steep drop in oil prices, geopolitical
More informationО КЛЮЧЕВОЙ СТАВКЕ RUSSIAN ECONOMIC OUTLOOK AND CHALLENGES TO MONETARY POLICY. December Bank of Russia Presentation for Investors
О КЛЮЧЕВОЙ СТАВКЕ RUSSIAN ECONOMIC OUTLOOK AND CHALLENGES TO MONETARY POLICY Bank of Russia Presentation for Investors December 16 USD per barrel RUB / USD 2 Oil Eхporters Production-cut Agreements Support
More informationFood supplements as part of the OTC Market
1/16/218 Food supplements as part of the OTC Market Hynek Valerián, IQVIA Copyright 218 IQVIA. All rights reserved. + Global and European context for OTC market Table of Contents + Czech Republic OTC and
More informationThe Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th
The Pharmaceutical Market: Did we Learned the Crisis Lessons? Petru Crăciun ZF Pharma Bucharest 2014, September 29th The Pharmaceutical Market Pharma Market MAT(2008 - M6) MAT(2014 - M6) +/- % Total Units
More informationThe need for generic policies as part of health reform. Richard Laing EMP/WHO for Geneva 2013
The need for generic policies as part of health reform Richard Laing EMP/WHO for Geneva 2013 Even after patent expiration brands still retain a sizeable volume share in some countries VOLUME MARKET SHARE
More informationGeneric market trends in Europe
Generic market trends in Europe Oslo, May 6, 2010 Per Troein, Vice President Strategic Partners, IMS Health EMEA June 2009 Agenda Drug cost is becoming a key issue during the recession Resent trends in
More informationOctober Sanctions Guide. The Impact of Sanctions on Russia. Chris Weafer Senior Partner, Macro-Advisory Ltd
October 2017 Sanctions Guide The Impact of Sanctions on Russia Chris Weafer Senior Partner, Macro-Advisory Ltd cjw@macro-advisory.com 1 Summary Sanctions have created a great deal of uncertainty in the
More informationSTADA KEY FIGURES. 02 STADA Key Figures. 6 months 2015 Jan. 1 June 30 ± % 6 months 2016 Jan. 1 June 30. Key figures for the Group in million
02 STADA Key Figures STADA KEY FIGURES Key figures for the Group in million 6 months 2016 Jan. 1 June 30 6 months 2015 Jan. 1 June 30 ± % Group sales 1,034.7 1,025.9 +1% Generics (core segment) 603.8 615.3-2%
More informationPrescription medicines trends: an overview and perspective on two therapy areas
Prescription medicines trends: an overview and perspective on two therapy areas Sarah Rickwood, Vice President, IQVIA Copyright 217 IQVIA. All rights reserved. We will discuss four issues Global prescription
More informationThe analysis and outlook of the current macroeconomic situation and macroeconomic policies
The analysis and outlook of the current macroeconomic situation and macroeconomic policies Chief Economist of the Economic Forecast Department of the State Information Centre Wang Yuanhong 2014.05.28 Address:
More informationAnti-crisis State Policy in Russia
1 Anti-crisis State Policy in Russia Vera Kononova Institute for Complex Strategic Studies 1 December 2016 Seminar Outline 1. Anti-crisis Policy Goals The main goals and targets adopted by the Government
More informationRole of Russia in the global company. Investments and import to Russia. 2 nd Survey. 2017
Role of Russia in the global company Investments and import to Russia. 2 nd Survey. 2017 Prepared by GfK for the American Chamber of Commerce in Russia, May 2017 1 Survey description 2 nd survey. 2017
More informationUKRAINE WEEK HIGHLIGHTS
UKRAINE WEEK HIGHLIGHTS June 11, 2012: According to rating prepared by Business Insider company, Ukraine occupied 4 th place among the most default-risky countries. Experts counted the cost of insuring
More informationAngola - Economic Report
Angola - Economic Report Index I. Assumptions on National Policy and External Environment... 2 II. Recent Trends... 3 A. Real Sector Developments... 3 B. Monetary and Financial sector developments... 5
More informationFREE ARTICLE. Russian pharmaceutical market overview. Source: Pharma Poland News
FREE ARTICLE Russian pharmaceutical market overview Source: Pharma Poland News July 2006 Last year, the Russian pharmaceutical market expanded at an unprecedentedly high rate of 35%, much higher than the
More informationSEE pharmaceutical market healthy in 2010
SEE pharmaceutical market healthy in 2010 The pharmaceutical market in Southeast Europe (SEE) continued to grow in 2010 despite the economic volatility brought on by the global financial crisis. Pharmaceutical
More informationChasing Opportunity at the County Level: The New Growth Area for China s Pharmaceutical Market
www.pwccn.com Chasing Opportunity at the County Level: The New Growth Area for China s Pharmaceutical Market December 2015 The promising county level pharmaceutical market As the world s fastest-growing
More informationEGP 2.9 BN 51.1% y-o-y. EGP 216 MN 44.9% y-o-y. EGP 92 MN 69.4% y-o-y. EGP 28 MN 46.3% y-o-y. EGP 36 MN 88.4% y-o-y.
EARNINGS RELEASE Ibnsina Pharma Releases Audited Results Ibnsina Pharma starts 2018 off strong with year-on-year revenue and EBITDA growth of 51% and 69% respectively in 1Q2018, ensuring a sustained growth
More informationOutlook for Economic Activity and Prices (April 2010)
April 30, 2010 Bank of Japan Outlook for Economic Activity and Prices (April 2010) The Bank's View 1 The global economy has emerged from the sharp deterioration triggered by the financial crisis and has
More informationIntroduction to DOC Generici Jefferies Conference November 18-19, 2015
Introduction to DOC Generici Jefferies Conference November 18-19, 2015 INTRODUCTION TO DOC GENERICI The generics market in Italy DOC Generici: Leading Independent player 1 A LAND OF OPPORTUNITY Italy Europe
More informationResearch Report on Belarus
Research Report on Belarus 18 January 219 Responsible Expert: Vladimir Gorchakov Rating Associate For further information contact: Rating-Agentur Expert RA GmbH Walter-Kolb-Strasse 9-11, 694 Frankfurt
More informationFiscal 2009 Economic Outlook and Basic Stance for Economic and Fiscal Management
Provisional Translation Fiscal 2009 Economic Outlook and Basic Stance for Economic and Fiscal Management January 19, 2009 Cabinet Decision 1. The Japanese economy in FY2008 In FY2008, facing the global
More informationFacts from IQVIA M Copyright 2017 IQVIA. All rights reserved.
Facts from IQVIA M10 2018 Copyright 2017 IQVIA. All rights reserved. Russia pharma market growth in January-October 2018 Market grew by 3, in value and decreased by 2,9% in volume VALUE, BLN RUB VOLUME,
More informationTHIRD-PARTY PHARMACY RECONCILIATION
THIRD-PARTY PHARMACY RECONCILIATION Billy Caster Sales Solution Expert Inmar Healthcare Network Jon Brumbaugh Sr. Manager, Product Inmar Healthcare Network Session Description A discussion and presentation
More informationOriola Corporation Financial Statements 2017
Oriola Corporation Financial Statements 13 February 2018 13.2.2018 1 Oriola New contracts in Healthcare Sweden doubled the business area net sales Oriola expert services portfolio grew with Swedish ICTHS
More informationSTADA: Strong growth continues in H1/2006 sales +18%, net income +32%
Corporate News STADA: Strong growth continues in H1/2006 sales +18%, net income +32% Important items at a glance As expected, Group sales increases strongly in H1/2006 by +18% to EUR 580.0 million Net
More informationValentyn Povroznyuk, Radu Mihai Balan, Edilberto L. Segura
September 214 GDP grew by 1.2% yoy in Q2 214. Industrial output growth was equal to 1.4% yoy in June 214. The consolidated budget deficit narrowed to.2% of GDP in January-July 214. Consumer inflation slightly
More informationECONOMIC PROFILE OF NORWAY
5/31/2017 ECONOMIC PROFILE OF NORWAY Submitted to Dr. Ahmed Tazmeen Department of Economics North South University Prepared & Submitted by Fatema Zohara ID: 161-2861-085 MPPG 6th Batch North South University
More informationCurrent trends in generic medicines in the Middle East: challenges and opportunities. Mazen Darwazah Vice Chairman, Hikma Pharmaceuticals PLC
Current trends in generic medicines in the Middle East: challenges and opportunities Mazen Darwazah Vice Chairman, Hikma Pharmaceuticals PLC Middle East and North African pharmaceutical markets Middle
More informationPortugal Q Portugal. Lisbon, April 26th 2012
Q1 2012 Lisbon, April 26th 2012 Disclaimer 2 Banco Santander, S.A. ("Santander") cautions that this presentation contains forward-looking statements within the meaning of the US Private Securities Litigation
More information1. Introduction Executive Summary Market Survey Evaluation of Product/Market Suitability SWOT Analysis...
Date June 2014 1. Introduction... 2 2. Executive Summary... 2 3. Market Survey... 3 4. Evaluation of Product/Market Suitability... 5 5. SWOT Analysis... 6 The Trade Council is pleased to submit a brief
More informationECONOMY REPORT - JAPAN
ECONOMY REPORT - JAPAN (Extracted from 2001 Economic Outlook) REAL GROSS DOMESTIC PRODUCT The Japanese economy was on a gradual recovery from the trough of the business cycle in April 1999, helped by both
More informationAccess to Medicines in Low and Middle Income Countries: Goals and Challenges. Andreas Seiter The World Bank August 2013
Access to Medicines in Low and Middle Income Countries: Goals and Challenges Andreas Seiter The World Bank August 2013 1 The World Bank and its clients Financing (IDA, subsidized) Low-Income Countries
More informationRussia: Macro Outlook for 2019
October 2018 Russia: Macro Outlook for 2019 Natalia Orlova Head of Alfa Bank Macro Insights +7 495 795 36 77 norlova@alfabank.ru Egypt Saudi Arabia Brazil S. Africa UAE Iraq China Japan US Mexico UK Russia
More informationSigma Pharmaceuticals Limited
Investor Relations Contact: Gary Woodford Corporate Affairs Manager Gary.Woodford@signet.com.au Phone: 03 9215 9632 Mobile: 0417 399 204 Mark Hooper CEO and Managing Director Gary Woodford Corporate Affairs
More informationMonetary Policy Report 3/11. Charts
Monetary Policy Report / Charts Chart. Projected output gap¹) for Norway's trading partners. Per cent. Q Q - - - - MPR / MPR / - - - - - 7 9 ) The output gap measures the percentage deviation between GDP
More informationEurozone. EY Eurozone Forecast March 2015
Eurozone EY Eurozone Forecast March 2015 Austria Belgium Cyprus Estonia Finland France Germany Greece Ireland Italy Latvia Lithuania Luxembourg Malta Netherlands Portugal Slovakia Slovenia Spain Outlook
More informationReinsurance Market in Russia: Future Outlook. Joint analytical report of ARIA and RNRC
Reinsurance Market in Russia: Future Outlook Joint analytical report of ARIA and RNRC 1 Summary The reinsurance market in Russia needs a fresh start. The scope of internal reinsurance in Russia is declining
More information5. Bulgarian National Bank Forecast of Key
5. Bulgarian National Bank Forecast of Key Macroeconomic Indicators for 2018 2020 The BNB forecast of key macroeconomic indicators is based on data published as of 15 June 2018. ECB, EC and IMF assumptions
More informationCHALLENGES WITH ASEAN PHARMACEUTICAL REGULATION SCHEMES TO OTC PRODUCTS INDONESIA EXPERIENCE RACHMADI JOESOEF GP FARMASI - INDONESIA
CHALLENGES WITH ASEAN PHARMACEUTICAL REGULATION SCHEMES TO OTC PRODUCTS INDONESIA EXPERIENCE RACHMADI JOESOEF GP FARMASI - INDONESIA 1 OUTLINE INTRODUCTION 2 3 4 5 6 SCOPE OF REGULATION SCHEME CHALLENGES
More informationDisease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry
Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Jeffrey A. Bourret, M.S., R.Ph., FASHP Senior Director, Managed Markets Healthcare Systems Marketing
More informationSpain s economic recovery gains speed, but the external balance worsens
Spain s economic recovery gains speed, but the external balance worsens Ángel Laborda and María Jesús Fernández 1 Correction of imbalances, together with structural reform and exogenous factors, supports
More informationSouth African Reserve Bank STATEMENT OF THE MONETARY POLICY COMMITTEE. Issued by Lesetja Kganyago, Governor of the South African Reserve Bank
South African Reserve Bank PRESS STATEMENT EMBARGO DELIVERY 23 November 2017 STATEMENT OF THE MONETARY POLICY COMMITTEE Issued by Lesetja Kganyago, Governor of the South African Reserve Bank Since the
More informationInternational Journal of Business and Economic Development Vol. 4 Number 1 March 2016
A sluggish U.S. economy is no surprise: Declining the rate of growth of profits and other indicators in the last three quarters of 2015 predicted a slowdown in the US economy in the coming months Bob Namvar
More informationState of the Turkish Economy. Emre Deliveli TOBB ETU, October
State of the Turkish Economy Emre Deliveli TOBB ETU, October 11 2005 State of the Turkish Economy Slide 2 Agenda Overview of the Turkish economy Risks and priorities New anchor: EU What are the policy
More informationInstitutional Presentation. June/2016
V2 Institutional Presentation June/2016 Disclaimer This release contains forward-looking statements that are exclusively related to the prospects of the business, its operating and financial results, and
More informationM.Video 2015 Investor Presentation. April, 2016
M.Video 2015 Investor Presentation April, 2016 Content and liability disclaimer The information contained in this presentation or enclosed herewith is provided and intended for informational purposes only
More information4. SOME KEYNESIAN ANALYSIS
4. SOME KEYNESIAN ANALYSIS Fiscal and Monetary Policy... 2 Some Basic Relationships... 2 Floating Exchange Rates and the United States... 7 Fixed Exchange Rates and France... 11 The J-Curve Pattern of
More informationBelarus Economy as part of Common Economic space: analysis and forecast
Institute of Economic Forecasting, Russian Academy of Sciences Belarus Economy as part of Common Economic space: analysis and forecast Performed by Savchishina Ksenia Institute of Economic Forecasting
More informationFY 2017 Results. March 6, 2018
FY 2017 Results March 6, 2018 Forward looking statements This Presentation may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management s current
More informationBOFIT Forecast for Russia
BOFIT Forecast for Russia 24.9.2015 BOFIT Russia Team BOFIT Forecast for Russia 2015 2017 Bank of Finland BOFIT Institute for Economies in Transition Bank of Finland BOFIT Institute for Economies in Transition
More informationFiscal Risks in Italy
Fiscal Risks in Italy IMF Conference on Fiscal Risks Paris October 28-29, 2008 Lorenzo Codogno Italy s Ministry of the Economy and Finance (MEF) Department of the Treasury, Economic and Financial Analysis
More informationRUSSIAN ECONOMIC OUTLOOK AND MONETARY POLICY. RUSSIA S ECONOMIC OUTLOOK AND MONETARY POLICY February 2019
% RUSSIA S ECONOMIC OUTLOOK AND February 19 Consumer prices In January 19, annual inflation held at the lower bound of the Bank of Russia expectations (.% YoY). Faster growth of food prices to.% (vs.7%
More informationMeeting with Analysts
CNB s New Forecast (Inflation Report III/2018) Meeting with Analysts Karel Musil Prague, 3 August 2018 Outline 1. Assumptions of the forecast 2. The new macroeconomic forecast 3. Comparison with the previous
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationSTADA: Growth after nine months of 2006: Sales +18%, adjusted net income +27%
Corporate News STADA: Growth after nine months of 2006: Sales +18%, adjusted net income +27% Important items at a glance Nine-month figures 2006 confirm sustainable growth: o Group sales EUR 870.3 million
More informationMACROECONOMIC INDICATORS OF RUSSIA
MACROECONOMIC INDICATORS OF RUSSIA 2007 2011 by Prof. Dr. Mstislav AFANASIEV rector www.abik.ru February 2011 GDP in Russia and Japan Source: International Monetary Fund, World Economic Outlook Database,
More informationBOFIT Forecast for Russia
BOFIT Forecast for Russia BOFIT Russia Team BOFIT Forecast for Russia 2018 2020 Bank of Finland BOFIT Institute for Economies in Transition Bank of Finland BOFIT Institute for Economies in Transition PO
More informationFinancial Market Outlook: Further Stock Gain on Faster GDP Rebound and Earnings Recovery. Year-end Target Raised
For Market Commentary Interviews Contact: Lisa Villareal, 973-367-2503/lisa.villareal@prudential.com Financial Market Outlook & Strategy: FurtherStock Gains Likely, Year-end Target Raised. Bond Under Pressure
More informationUS Economy Update May 2014
US Economy Update May 2014 MACRO REPORT Key Insights Monica Defend Head of Global Asset Allocation Research Annalisa Usardi Economist, US & LATAM Global Asset Allocation Research Also contributing Riccardo
More informationBaltic Nordic Roadshow presentation. October, 2015
Baltic Nordic Roadshow presentation October, 2015 In This Presentation Olainfarm the background and the key facts; The Group Company s recent performance; Ukraine and Russia: present and prospects; Future
More informationSpanish economic outlook. June 2017
Spanish economic outlook June 2017 1 2 3 Spanish economy a pleasant surprise Growth drivers Forecasts once again bright One of the most dynamic economies in Europe Spain growing at a faster rate than EMU
More informationSupply and Demand over the Business Cycle
Session 9. The Model at Work. v Business Cycles v The Economy in the Long Run: Recession and recovery Monetary expansion The everyday business of the central bank v Summing up: The IS/LM Model in Closed
More informationEconomic Profile of Bhutan
Economic Profile of Bhutan Submitted to: Dr. Ahmed Tazmeen Assistant Professor, Department of Economics North South University Submitted By: Namgay Wangmo MPPG 6th Batch ID # 1612872085 Date of Submission:
More informationYEREVAN 2014 MACROECONOMIC OVERVIEW OF ARMENIA
YEREVAN 2014 MACROECONOMIC OVERVIEW OF ARMENIA MACROECONOMIC OVERVIEW In the early 1990s, a sharp boost of unemployment, reduction of real wages, shrinkage of tax-base, persistent cash shortages of GoA
More informationEmerging Markets Debt: Outlook for the Asset Class
Emerging Markets Debt: Outlook for the Asset Class By Steffen Reichold Emerging Markets Economist May 2, 211 Emerging market debt has been one of the best performing asset classes in recent years due to
More informationRecordati S.p.A First Quarter Results Conference Call. Thursday, May, 05, 2016, 16:00 (CET) MODERATORS:
Recordati S.p.A. 2016 First Quarter Results Conference Call Thursday, May, 05, 2016, 16:00 (CET) MODERATORS: FRITZ SQUINDO, CHIEF EXECUTIVE OFFICER MARIANNE TATSCHKE, DIRECTOR OF INVESTOR RELATIONS OPERATOR:
More informationThe Chilean Economy After the World Crisis: Perspectives. Hernán Gutiérrez B. Director Department of Economic and Trade Embassy of Chile
The Chilean Economy After the World Crisis: Perspectives Hernán Gutiérrez B. Director Department of Economic and Trade Embassy of Chile Index Framework of the Chilean Economy The Global Financial Crunch
More informationMOBERG PHARMA AB (PUBL) Year-End Report 2014 Combining Commercial and Innovation Excellence to Develop Unique Products for Underserved Niches
MOBERG PHARMA AB (PUBL) Year-End Report 2014 Combining Commercial and Innovation Excellence to Develop Unique Products for Underserved Niches Stockholm Corporate Finance Life Science/Healthcare day, March
More informationQ3 FY09 Results Update
Q3 FY09 Results Update January 20, 2009 1 Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking
More informationRomania the next best thing. Generali Romania November 12, 2009 Bucharest
Romania the next best thing Generali Romania November 12, 2009 Bucharest Content Current Romanian economic outlook. And impact on the insurance industry Generali PPF on the CEE markets Why could Romania
More informationMACROECONOMIC FORECAST
MACROECONOMIC FORECAST Spring 17 Ministry of Finance of the Republic of Bulgaria Bulgarian economy is expected to expand by 3% in 17 driven by domestic demand. As compared to 16, the external sector will
More informationStanding strong for payers and patients
Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor
More informationDEVELOPMENT TRENDS, INFLUENCE FACTORS, FORECAST MACROINDICATORS OF UKRAINE S ECONOMY FOR THE PERION UNTIL 1015
UKRAINE COUNTRY REPORT: DEVELOPMENT TRENDS, INFLUENCE FACTORS, FORECAST MACROINDICATORS OF UKRAINE S ECONOMY FOR THE PERION UNTIL 1015 New York, October 22-24, 2012 Valeriy Heyets, Maria Skrypnychenko
More informationHealthcare. abc. Healthcare team
team Luciano Campos* Analyst HSBC Bank Brasil SA +55 11 3371 8194 luciano.t.campos@hsbc.com.br Caio Moscardini* Analyst HSBC Bank Brasil SA +55 11 3847 5635 caio.s.moscardini@hsbc.com.br *Employed by a
More informationFISCAL COUNCIL OPINION ON THE SUMMER FORECAST 2018 OF THE MINISTRY OF FINANCE
FISCAL COUNCIL OPINION ON THE SUMMER FORECAST 2018 OF THE MINISTRY OF FINANCE September 2018 Contents Opinion... 3 Explanatory Report... 4 Opinion on the summer forecast 2018 of the Ministry of Finance...
More informationAndreas Seiter, World Bank
Pharmaceutical Pricing and Reimbursement Inputs from a Global Perspective Vienna, June 2007 Andreas Seiter, World Bank World Bank support for health systems development Loans for capacity building through
More informationThe Russian economy: growth under sanctions, top longterm trends, scenarios for the future
The Russian economy: growth under sanctions, top longterm trends, scenarios for the future Prof. Dr. Yakov Mirkin The world oil / gas prices fell, the dollar strengthened against the euro Sanctions Рarting
More informationOriola KD Corporation. Carnegie Lunch Seminar Helsinki, 11 May 2012
Oriola KD Corporation Eero Hautaniemi President & CEO Oriola KD Corporation Joni Ihantola Vice President, Treasury & IR Oriola KD Corporation Carnegie Lunch Seminar Helsinki, 11 May 2012 Key Figures Q1
More informationRavi Menon: Economic and financial developments in Singapore
Ravi Menon: Economic and financial developments in Singapore Opening remarks by Mr Ravi Menon, Managing Director of the Monetary Authority of Singapore (MAS), at the MAS Annual Report 2010/11 Press Conference,
More informationFINANCIAL STABILITY IN THE REPUBLIC OF BELARUS
NATIONAL BANK OF 1 THE REPUBLIC OF BELARUS FINANCIAL STABILITY IN THE REPUBLIC OF BELARUS 2010 MINSK, 2011 2 This publication has been prepared by the Banking Supervision Directorate in concert with the
More informationTRENDS AND NEW TENDENCIES IN PRODUCTS, DISTRIBUTION & MARKETS
TRENDS AND NEW TENDENCIES IN PRODUCTS, DISTRIBUTION & MARKETS Maxim Chernin CEO at IC Sberbank life insurance Ltd., Chairman of the Life Insurance Committee All-Russian Insurance Union Russia 8 499 707
More informationBank Millennium Group
Bank Millennium Group 2008 Results and New Strategy Millennium 2010 Presentation for Bank Millennium s General Meeting of Shareholders 27 March 2009 1 Disclaimer The matters discussed in this presentation
More informationFlorida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011
Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011 Keeping your money in your pocket, where it belongs. Risk
More informationEconomic Projections for
Economic Projections for 2015-2017 Article published in the Quarterly Review 2015:3, pp. 86-91 7. ECONOMIC PROJECTIONS FOR 2015-2017 Outlook for the Maltese economy 1 The Bank s latest macroeconomic projections
More informationUKRAINE WEEK HIGHLIGHTS
UKRAINE WEEK HIGHLIGHTS August 29, 2011: Volume of sales of industrial products in Ukraine in January-July 2011 amounted to UAH 619.6 billion. In 7 months of 2010Y volume of sales of industrial products
More informationLeumi. Global Economics Monthly Review. Arie Tal, Research Economist. May 8, The Finance Division, Economics Department. leumiusa.
Global Economics Monthly Review May 8, 2018 Arie Tal, Research Economist The Finance Division, Economics Department Leumi leumiusa.com Please see important disclaimer on the last page of this report Key
More information